Sponsored Content
Sponsored content is a special advertising section provided by IT vendors. It features educational content and interactive media aligned to the topics of this web site.
RAAPID
RAAPID develops AI-powered risk adjustment solutions for healthcare payers, providers, and supporting organizations. The company's HITRUST-certified platform uses Neuro-Symbolic AI to identify chronic conditions, determine HCC codes, and provide explainable documentation for complete audit defense. Backed by M12 (Microsoft's venture fund), RAAPID serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs with both retrospective and prospective risk capture capabilities. Founded by healthcare technology veterans with over 20 years of experience, RAAPID is headquartered in Louisville, Kentucky.
-
RevSpring debuts AI agent for personalized payment plans
A new conversational AI agent will integrate with RevSpring's patient payment portal to offer personalized payment plans and ...
-
Patient liability drives about half of hard-to-collect bills
A new analysis finds that patients owe more on large medical bills, creating larger obstacles for providers to collect these ...
-
Investor suit says UnitedHealth ignored governance, cybersecurity gaps for years
The laundry list of allegations include claims that UnitedHealth deceived investors, artificially inflated share prices and ...
-
Cyberattack forces temporary closure of 83 AnMed facilities
Nonprofit health system AnMed's medical group and imaging offices will be closed on July 27 as it responds to a cyberattack; ...
-
Vulnerable populations tap telemental healthcare, study shows
Telemental health use varies by age, gender, diagnosis and location, with utilization highest in socially vulnerable areas ...
-
Zocdoc invites AI agents to book appointments on behalf of patients
It’s a “contrarian move” for the company as much of the industry remains wary of agentic AI, according to Zocdoc CEO Dr. Oliver ...
-
Popular AI models get medication doses wrong, some dangerously: Doximity
The clinical AI company’s research shows that its new dose verification tool outperformed general-use AI models. It’s Doximity’s ...
-
HHS unveils breast cancer screening initiative
The HHS initiative will focus on patient education about dense breast cancer screening, coming at a time when overall cancer ...